北美病毒样颗粒市场预测至 2028 年 - 按产品类型（肝炎、癌症/HPV 和戈谢病）、来源（酵母、昆虫细胞、植物等）和应用（疫苗）划分的 COVID-19 影响和区域分析和治疗）

市场介绍

北美病毒样颗粒市场分析基于三大主要因素国家：美国、加拿大和墨西哥。在北美各省中，由于报告的病毒感染（例如变异流感病毒），美国拥有最大的 VLP 市场规模。美国疾病控制与预防中心（CDC）的报告称，大多数变异病毒的情况主要发生在18岁或以下发病的儿童（ CDC）。此外，生物制药公司持续不断的减毒活疫苗研发活动对市场增长产生了积极影响。

在北美省份，美国是受影响最严重的国家，因为到新冠肺炎 (COVID-19)。这是由于美国在 COVID-19 爆发期间反应不平衡，加上检测资源不足。为了克服 COVID-19 的传播率，所有高度关注重组 COVID-19 疫苗的生物制药公司都对疫苗的开发处于紧张状态。由于重组疫苗包括重组刺突蛋白疫苗、重组受体结合域疫苗和病毒样颗粒疫苗，因此它已获得高度重视。此外，通过修饰颗粒表面以将其引入特定细胞或组织中，更有效和更有针对性的 VLP 形式的开发可能会在未来几年得到发展。 VLP 生产的最新进展涉及不同类型的表达系统，以及用于预防传染病的疫苗的开发和应用。在北美地区，目前正在开发 COVID-19 疫苗的国家包括美国、加拿大和古巴。其中，美国拥有11种疫苗，加拿大和古巴拥有3种疫苗。此外，还有六种由VLP组成的蛋白亚单位疫苗、五种载体疫苗和五种核酸疫苗。但病毒样颗粒的制造在设计、纯化和储存方面仍然具有挑战性。挑战主要与处理呼吸系统问题的生物加工技术有关。然而，随着技术的进步，最终在不久的将来开发出一系列新颖、稳定、高效的基于VLP的候选疫苗。

市场概况和Dynamics

北美类病毒颗粒市场预计将从2021年的19.2837亿美元增长到2021年的33.1249亿美元。 2028；预计 2021 年至 2028 年复合年增长率为 8.0%。医疗保健市场的各个参与者和研究机构都积极参与产品创新和开发。使用病毒样颗粒是生物制药行业中使用的一种新兴方法。由于病毒样颗粒缺乏病毒成分，因此它们比实际的病毒成分更容易处理。 VLP 可用于辅助药物输送、成像、免疫治疗和治疗诊断。例如，根据 NCBI 2020 年 6 月发表的一项研究，VLP 可以纳米颗粒的形式用于光热疗法、PET 和 CT 成像、MRI 造影剂载体、光学成像、炎症和自身免疫性疾病疫苗等应用，癌症免疫疗法和小分子药物输送（在癌症治疗中）。因此，VLP 的此类潜在应用预计将在预测期内为市场参与者提供增长机会。

关键细分市场

从产品类型来看，肝炎细分市场在2021年北美病毒样颗粒市场中占据最大份额。从来源来看，酵母细分市场2021年北美病毒样颗粒市场份额最大。从应用来看，2021年疫苗领域在病毒样颗粒市场占有较大份额。

主要来源和上市公司

准备本报告时参考的一些主要一手和二手来源北美的类病毒颗粒市场包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司是默克公司（Merck & Company）。有限公司；葛兰素史克公司；辉瑞公司；赛诺菲；印度血清研究所列兵。有限公司；巴拉特生物技术公司； LG化学； VBI 疫苗公司；和 Dynavax Technologies 等。

购买报告的理由

了解北美病毒样颗粒市场格局并确定最有可能保证强劲回报的细分市场
了解北美病毒样颗粒市场不断变化的竞争格局，保持领先地位
高效通过识别最有可能销售前景的细分市场，规划北美类病毒颗粒市场的并购和合作交易
帮助通过敏锐和全面的分析做出明智的业务决策北美病毒样颗粒市场各个细分市场的市场表现
获取北美地区2021-2028年各个细分市场的市场收入预测。

北美类病毒颗粒市场细分

北美病毒样颗粒市场 - 按产品类型

肝炎
癌症/HPV
戈谢病

北美病毒样颗粒市场 - 按来源

酵母
昆虫细胞
植物
其他

北美病毒样颗粒市场 - 作者：应用

疫苗
治疗

北美病毒样颗粒市场 - 按国家/地区

美国
加拿大
墨西哥

北美病毒样颗粒市场 - 公司提到

Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        North America Virus-like Particles Market – By Product Type
1.3.2        North America Virus-like Particles Market – By Source
1.3.3        North America Virus-like Particles Market – By Application
1.3.4        North America Virus-like Particles Market – By Country
2.           North America Virus-like Particles Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           North America Virus-like Particles Market Landscape
4.1         Overview
4.2         PEST Analysis
4.3         Experts Opinion
5.           North America Virus-like Particles Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Growing Prevalence of Infectious Viral Diseases
5.1.2        The Elevating Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2         Market Restraints
5.2.1        Presence of Alternative Technologies for Viral Vaccine Production
5.3         Market Opportunities
5.3.1        Raising Potential Applications in Therapeutics and Diagnostics
5.4         Future Trends
5.4.1        Constant Demand for Innovative and Effective Products
5.5         Impact Analysis
6.           North America Virus-like Particles Market Analysis
6.1         North America Virus-like Particles Market Revenue Forecast and Analysis
7.           North America Virus-like Particles Market Analysis – by Product Type
7.1         Overview
7.2         North America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3         Hepatitis
7.3.1        Overview
7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4         Cancer/ Human Papillomavirus (HPV)
7.4.1        Overview
7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5         Gaucher Disease
7.5.1        Overview
7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.           North America Virus-like Particles Market Analysis – By Source
8.1         Overview
8.2         North America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3         Yeast
8.3.1        Overview
8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4         Plant
8.4.1        Overview
8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5         Insect Cell
8.5.1        Overview
8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6         Others
8.6.1        Overview
8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.           North America Virus-like Particles Market Analysis – By Application
9.1         Overview
9.2         North America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3         Vaccines
9.3.1        Overview
9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4         Therapeutics
9.4.1        Overview
9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.        North America Virus-like Particles Market – Country Analysis
10.1      Overview
10.1.1     North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
10.1.1.1       US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1       Overview
10.1.1.1.2       US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3       US: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.4       US: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)
10.1.1.1.5       US: Virus-like Particles Market, by Application, 2019–2028 (US$ Million)
10.1.1.2       Canada: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1       Overview
10.1.1.2.2       Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3       Canada: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.4       Canada: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)
10.1.1.2.5       Canada Virus-Like Particles Market, by Application, 2019–2028 (US$ Million)
10.1.1.3       Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1       Overview
10.1.1.3.2       Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3       Mexico: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.4       Mexico: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)
10.1.1.3.5       Mexico: Virus-like Particles Market, by Application, 2019–2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on North America Virus-like Particles Market
11.1      North America: Impact Assessment of COVID-19 Pandemic
12.        North America Virus-like Particles Market–Industry Landscape
12.1      Overview
12.2      Organic Developments
12.2.1     Overview
12.3      Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1      Merck & Co., Inc.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      GlaxoSmithKline plc.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      Pfizer Inc.
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      Dynavax Technologies
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      Sanofi
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Serum Institute of India Pvt. Ltd.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      BHARAT BIOTECH
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      LG Chem
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9      VBI Vaccines Inc.
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             North America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2.             US Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3.             US Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 4.             US Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)
Table 5.             Canada: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6.             Canada Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 7.             Canada Virus-Like Particles Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8.             Mexico: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 9.             Mexico Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)
Table 10.          Mexico Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)
Table 11.          Organic Developments Done by Companies
Table 12.          Inorganic Developments Done by Companies
Table 13.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES
Figure 1.           North America Virus-like particles Market Segmentation
Figure 2.           North America Virus-like particles Market Segmentation, By Country
Figure 3.           North America Virus-like Particles Market Overview
Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in North America Virus-like particles Market
Figure 5.           The US to Show Significant Growth during Forecast Period
Figure 6.           North America Virus-like Particles Market, Industry Landscape
Figure 7.           North America PEST Analysis
Figure 8.           North America Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9.           North America Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10.        North America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14.        North America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19.        North America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22.        North America: Virus-like Particles Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23.        North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 24.        US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        Impact of COVID-19 Pandemic in North American Country Markets

Merck & Co., Inc.
GlaxoSmithKline plc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH
LG Chem
VBI Vaccines Inc.
Dynavax Technologies

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022

North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022

North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.